January 18, 2017 — LindaCare announced that it will open a new customer support facility in Connecticut to support growing interest in their vendor-neutral software platform for monitoring patients with chronic heart disease and other conditions.
The announcement of the launch into the U.S. market follows substantial interest in LindaCare's solutions at the Heart Rhythm Society conference last year, the company said. The award of a $500,000 investment from Connecticut Innovations (CI) following success in their VentureClash investment challenge has allowed LindaCare to accelerate their plans to invest beyond their European base.
LindaCare’s first version of the product is a web-based software platform for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) and suffering from chronic heart failure (CHF) and cardiac arrhythmia; this accounts for an estimated total of about 10 million patients worldwide today.
The Connecticut office will initially comprise four sales and customer support professionals, with a planned rollout of further, localized support across the United States later in the year, bringing immediate access to high-quality support across multiple time zones.
In parallel, LindaCare is planning to provide Independent Diagnostic and Testing Facility (IDTF) patient monitoring services through accredited local service providers. These services will help to gather and analyze the remote data, thereby allowing busy medical professionals to focus on diagnosis and care of patients.
Miguel Maquieira, CTO and co-founder of LindaCare, indicated that a significant research and development phase is completing and the U.S. expansion will allow a new software suite and service model to be announced simultaneously in Europe and the U.S. in the next few weeks.
For more information: www.lindacare.com
August 15, 2024 
